問卷

TPIDB > Study Site

Study Site



National Taiwan University Hospital Hsin-Chu Branch

  • 0

    Total Beds

  • 0

    Total Doctors

篩選

List

126Cases

2020-12-31 - 2023-12-31

Phase III

A Phase III, Randomized, Double-Blind, Placebo-Controlled Study to Demonstrate the Efficacy and Safety of Tildrakizumab in Anti-TNF Experienced Subjects with Active Psoriatic Arthritis I (INSPIRE 1)
  • Condition/Disease

    Active Psoriatic Arthritis

  • Test Drug

    Tildrakizumab

Participate Sites
9Sites

Recruiting9Sites

2023-07-31 - 2026-05-27

Phase II

  • Condition/Disease

  • Test Drug

Participate Sites
8Sites

Recruiting8Sites

2018-12-01 - 2021-08-31

Phase II

A Randomized, Double-blind, Parallel-group, Multicenter Phase 2b Study to Assess the Efficacy and Safety of Two Different Doses of Vilaprisan (BAY1002670) Versus Placebo in Women With Symptomatic Endometriosis
  • Condition/Disease

    Endometriosis

  • Test Drug

    Vilaprisan (BAY 1002670)

Participate Sites
6Sites

Not yet recruiting3Sites

Terminated3Sites

2014-07-01 - 2017-12-31

Phase I

  • Condition/Disease

  • Test Drug

Participate Sites
3Sites

Terminated3Sites